← Back to Search

APIC for Older Adults (APIC Trial)

N/A
Waitlist Available
Research Sponsored by Mélanie Levasseur
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Restricted in at least one instrumental activity of daily living (e.g. house cleaning, shopping)
Aged 65 or older
Must not have
Moderate to severe cognitive impairments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12, 18, 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test an intervention called APIC, which is designed to help older adults maintain their health and social participation, and improve their life satisfaction. The study will also evaluate the costs of the intervention.

Who is the study for?
This trial is for older adults aged 65 or above who live at home or in senior residences, have difficulty with daily tasks like house cleaning or shopping, and understand French or English well. It's not suitable for those with moderate to severe cognitive impairments.
What is being tested?
The study tests the 'Personalised citizen assistance for social participation (APIC)' intervention aimed at improving health, social engagement, life satisfaction, and reducing healthcare service use among older adults by enhancing their social participation.
What are the potential side effects?
Since APIC is a non-medical intervention focusing on increasing social activities and support, it does not have typical medical side effects. However, participants may experience changes in their routine which could affect them positively or negatively.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need help with daily tasks like shopping or cleaning.
Select...
I am 65 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have significant memory or thinking problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12, 18, 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12, 18, 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
v2 of the 36-Item Short-Form Health Survey (SF-36) (''change'' is is being assessed)
Secondary study objectives
Life Satisfaction Index-Z
Social participation scale
Use of healthcare services-Standardized questionnaire

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Personalised citizen assistanceExperimental Treatment1 Intervention
The experimental group will receive the Personalised citizen assistance for social participation (APIC), i.e. weekly 3-hour personalised stimulation sessions by a trained volunteer over 12 months. Sessions will encourage empowerment, gradual mobilisation of personal and environmental resources, and community integration.
Group II: Control groupActive Control1 Intervention
The control group will receive the publicly-funded universal healthcare services available to all Quebecers.

Find a Location

Who is running the clinical trial?

Mélanie LevasseurLead Sponsor
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,394 Previous Clinical Trials
26,527,678 Total Patients Enrolled

Media Library

Personalised citizen assistance for social participation(APIC) Clinical Trial Eligibility Overview. Trial Name: NCT03161860 — N/A
Community Dwelling Older Adults Research Study Groups: Personalised citizen assistance, Control group
Community Dwelling Older Adults Clinical Trial 2023: Personalised citizen assistance for social participation(APIC) Highlights & Side Effects. Trial Name: NCT03161860 — N/A
Personalised citizen assistance for social participation(APIC) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03161860 — N/A
~22 spots leftby Dec 2025